Sguinzi R, Fiechter J, Bafumi L, Gremaud B, Geng B, Janiak P, Bühler L, Egger B
Department of General Surgery, Fribourg Cantonal Hospital, Fribourg, 1700, Switzerland.
Faculty of Science and Medicine - Section of Medicine, University of Fribourg, Fribourg, 1700, Switzerland.
Int J Colorectal Dis. 2025 May 14;40(1):115. doi: 10.1007/s00384-025-04906-w.
Sphincter-sparing low anterior resection (SSLAR) with neoadjuvant radio-chemotherapy has been developed to avoid abdomino-perineal amputation and permanent colostomy in patients with low rectal cancer. However, many patients develop symptoms known as low anterior resection syndrome (LARS), including fecal urgency, incontinence, and a sensation of incomplete evacuation. The Low Anterior Resection Syndrome Score (LARS Score), a validated tool developed by Emmertsen and Laurberg, is used to assess symptom severity and guide treatment.
We present a single-center cohort study including patients having undergone SSLAR for rectal cancer between 2014 and 2021 at Fribourg Cantonal Hospital. Initial LARS-scores were obtained by completion of the QoL questionnaire. Patients with minor LARS (scores 21-29) were treated with electrostimulation and bio-feedback physiotherapy. Those with major LARS (scores > 29) were first investigated by anal manometry followed by physiotherapy. All treatments took place in 2022/2023. After treatment, LARS-scores were calculated again.
Of 54 patients included in the study, 18.5% had minor LARS, 40.8% major LARS, and 40.8% had no LARS. Of all patients with LARS, 18 (56%) completed pelvic physiotherapy, whereas 14 (44%) refused the treatment. Before and after pelvic physiotherapy, the median LARS score was 32 [interquartile range 29.50-38.50] and 22.5 [18.5-28], respectively (p < 0.001 according to Wilcoxon signed-rank test). Analysis of risk factors did not reveal any significant difference in age, gender, diabetes, nicotine or alcohol use, previous abdominal surgery, tumor stage, chemo/radiotherapy, type of operation and anastomosis, or anastomotic leakage.
Approximately half of patients undergoing SSLAR experience LARS, and approximately one-third develop the major form. LARS scores may significantly improve with specific physiotherapeutic measures that have therefore been introduced as a standard procedure for all SSLAR patients at our institution.
保留括约肌的低位前切除术(SSLAR)联合新辅助放化疗已被应用于避免低位直肠癌患者进行腹会阴联合切除术和永久性结肠造口术。然而,许多患者出现了被称为低位前切除综合征(LARS)的症状,包括排便急迫感、失禁以及排便不尽感。低位前切除综合征评分(LARS评分)是由埃默特森和劳尔伯格开发的一种经过验证的工具,用于评估症状严重程度并指导治疗。
我们进行了一项单中心队列研究,纳入了2014年至2021年期间在弗里堡州立医院接受直肠癌SSLAR手术的患者。通过完成生活质量问卷获得初始LARS评分。轻度LARS(评分21 - 29)的患者接受电刺激和生物反馈物理治疗。重度LARS(评分>29)的患者首先进行肛门测压,然后接受物理治疗。所有治疗均在2022/2023年进行。治疗后,再次计算LARS评分。
在纳入研究的54例患者中,18.5%为轻度LARS,40.8%为重度LARS,40.8%无LARS。在所有LARS患者中,18例(56%)完成了盆腔物理治疗,而14例(44%)拒绝了治疗。盆腔物理治疗前后,LARS评分中位数分别为32[四分位间距29.50 - 38.50]和22.5[18.5 - 28](根据Wilcoxon符号秩检验,p<0.001)。危险因素分析未发现年龄、性别、糖尿病、吸烟或饮酒、既往腹部手术、肿瘤分期、化疗/放疗、手术类型和吻合方式或吻合口漏有任何显著差异。
接受SSLAR手术的患者中约一半会出现LARS,约三分之一为重度形式。通过特定的物理治疗措施,LARS评分可能会显著改善,因此这些措施已被作为我们机构所有SSLAR患者的标准程序引入。